Yuhan Corp
KRX:000100

Watchlist Manager
Yuhan Corp Logo
Yuhan Corp
KRX:000100
Watchlist
Price: 115 100 KRW -1.79% Market Closed
Market Cap: 8.5T KRW
Have any thoughts about
Yuhan Corp?
Write Note

Relative Value

The Relative Value of one Yuhan Corp stock under the Base Case scenario is 61 026.94 KRW. Compared to the current market price of 115 100 KRW, Yuhan Corp is Overvalued by 47%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
61 026.94 KRW
Overvaluation 47%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
4
vs Industry
32
Median 3Y
2.2
Median 5Y
2.1
Industry
2.5
Forward
4
vs History
15
vs Industry
7
Median 3Y
40.6
Median 5Y
37.1
Industry
21.9
Forward
57.3
vs History
17
vs Industry
6
Median 3Y
40.2
Median 5Y
40.2
Industry
16.5
vs History
vs Industry
1
Median 3Y
-55.5
Median 5Y
-56.7
Industry
23.6
vs History
4
vs Industry
22
Median 3Y
2.1
Median 5Y
1.9
Industry
2.1
vs History
4
vs Industry
31
Median 3Y
2.1
Median 5Y
1.9
Industry
2.6
Forward
4
vs History
4
vs Industry
15
Median 3Y
6.9
Median 5Y
6
Industry
5.2
vs History
9
vs Industry
3
Median 3Y
41.9
Median 5Y
35.2
Industry
13.3
Forward
51.6
vs History
26
vs Industry
1
Median 3Y
85.3
Median 5Y
75.8
Industry
16.6
Forward
81.1
vs History
15
vs Industry
6
Median 3Y
37.6
Median 5Y
37.6
Industry
15.6
vs History
vs Industry
0
Median 3Y
-65
Median 5Y
-46.4
Industry
19.1
vs History
4
vs Industry
27
Median 3Y
1.9
Median 5Y
1.8
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Yuhan Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Yuhan Corp
KRX:000100
8.5T KRW 4.2 51.4 65.1 117.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
KR
Yuhan Corp
KRX:000100
Average P/E: 34.8
51.4
63%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top